Tenet Healthcare (THC) Tops Q2 EPS by 114c; offers guidance

Tenet Healthcare (NYSE: THC) reported Q2 EPS of $4.02, $1.14 better than the analyst estimate of $2.88. Revenue for the quarter came in at $5.27 billion versus the consensus estimate of $5.16 billion.

GUIDANCE:

Tenet Healthcare sees FY2025 EPS of $15.55-$16.21, versus the consensus of $12.83. Tenet Healthcare sees FY2025 revenue of $20.95-21.25 million, versus the consensus of $20.92 million.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
• Chewy (CHWY) Reports In-Line Q2 EPS, Offers Guidance
• Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance